Abiopharma

🔍 Mahoney Sean O (Executive)

Company: Aptiv PLC (APTV)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Acquired 4,000 shares of Ordinary Shares at $50.287 per share (Direct)
  Date: 2026-08-11 | Code: P | equity_swap_involved: false | shares_owned_after: 24,514.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 6,000 shares of Ordinary Shares at $50.2092 per share (Direct)
  Date: 2026-08-11 | Code: P | equity_swap_involved: false | shares_owned_after: 6,000.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 1,000 shares of Ordinary Shares at $50.28 per share (Direct)
  Date: 2026-08-11 | Code: P | equity_swap_involved: false | shares_owned_after: 1,000.00 | transaction_form_type: 4

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $50.275 to $50.32, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchage Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
• F2: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $50.18 to $50.27, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.